{
  "id": "5c9f7bb6ecadf2e73f00003e",
  "type": "yesno",
  "question": "Can therapeutic levels of  Vedolizumab be found in the breast milk of nursing mothers following treatment for Inflammatory bowel disease?",
  "ideal_answer": "vedolizumab can be detected in the breast milk of nursing mothers. although more data are imperative, the concentrations of vedolizumab in breast milk are minute and are therefore unlikely to result in systemic or gastro-intestinal immune-suppression of the infant.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28961712"
  ],
  "snippets": [
    {
      "text": "Vedolizumab can be detected in the breast milk of nursing mothers. Although more data are imperative, the concentrations of vedolizumab in breast milk are minute and are therefore unlikely to result in systemic or gastro-intestinal immune-suppression of the infant.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Although more data are imperative, the concentrations of vedolizumab in breast milk are minute and are therefore unlikely to result in systemic or gastro-intestinal immune-suppression of the infant.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Results\nVedolizumab was undetectable in breast milk in IBD patients before the first infusion of vedolizumab [n = 3] and in all of the healthy controls [n = 5].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, on serial measurements in breast milk after an infusion, drug levels did not surpass 480 ng/ml, which was roughly 1/100 of the comparable serum levels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, on serial measurements in breast milk after an infusion, drug levels did not surpass 480 ng/ml, which was roughly 1/100 of the comparable serum levels.<br><b>Conclusions</b>: Vedolizumab can be detected in the breast milk of nursing mothers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961712",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "However, on serial measurements in breast milk after an infusion, drug levels did not surpass 480 ng/ml, which was roughly 1/100 of the comparable serum levels.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961712",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}